Practical Alternative to Hospitalization
PATH
1 other identifier
interventional
72
1 country
1
Brief Summary
The investigators test the PATH program to evaluate whether the program allows patients to spend more days at home in comparison to patients who receive regular care. The program will involve patients from Penn Presbyterian Medical Center with a set of diagnoses and will provide patients with enhanced services upon discharge from the emergency department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2020
CompletedFirst Posted
Study publicly available on registry
November 20, 2020
CompletedStudy Start
First participant enrolled
February 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 2, 2021
CompletedAugust 10, 2022
August 1, 2022
5 months
November 16, 2020
August 9, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Days at home over 30 days
The number 30 minus the amount of days that patients spend in a hospital, nursing facility, or ED after discharge from the initial ED visit
30 days
Days that patients are expired
The number of days that patients are expired
30 days
Secondary Outcomes (5)
Impact of PATH on hospital operations - Capture rate
5 months
Quality of life at 30 days
5 months
Functional status at 30 days
5 months
Estimated cost (allowed charges) based on healthcare utilization
5 months
Impact of PATH on hospital operations - percentage of hospitalized patients
5 months
Study Arms (2)
PATH Intervention
EXPERIMENTALPatients in the treatment arm will receive a personalized plan of care upon discharge from the emergency department.
Routine Care
NO INTERVENTIONPatients in the control arm will receive standard-of-care services (the care plan that the emergency physician would normally offer if PATH were not available) without PATH enrollment.
Interventions
Patients will receive an enhanced level of care and service: 1. Discharge planning- PATH clinicians will develop an individualized treatment plan at time of ED discharge. Each patient will receive next-day phone call to monitor status. There will be additional patient and family education, triage of new or worsening symptoms, and additional telephone contact as determined in treatment plan. There will be communication with home health teams as needed. 2. Care coordination- PATH clinicians will arrange necessary primary medical doctor and specialty appointments. They will also communicate treatment plan to outpatient provider and arrange transportation for patients. 3. Home monitoring/ Home Health Services- If patients are eligible and consent to home health services, they will be enrolled in Penn Medicine Home Health (PMHH). This will include virtual home monitoring, skilled nurse care, home physical and occupational therapists, social work services, and wound care.
Eligibility Criteria
You may qualify if:
- Stable (Patients are deemed stable by ED clinician and PATH clinician per review of vital signs, history, exam, test results, and functional status)
- Have active insurance
- Domiciled at home (Patients must live in the community and not in nursing facility, shelter, or otherwise homeless)
- Safe home environment
- Live in Penn Medicine Home Health (PMHH) geographic catchment if enrolled in PMHH services
You may not qualify if:
- Substance use disorder (No active untreated SUD, including alcohol, opioids, cocaine, or stimulants)
- Serious mental health condition
- Police custody
- Homelessness
- Anticipated procedures or surgeries
- IV access (Patients with need for home infusion services or frequent blood testing after discharge must have standard level of IV access)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Independence Blue Crosscollaborator
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Austin Kilaru, MD, MSHP
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2020
First Posted
November 20, 2020
Study Start
February 9, 2021
Primary Completion
July 2, 2021
Study Completion
July 2, 2021
Last Updated
August 10, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share